In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA How different peptide therapies may affect your body Prenuvo blog FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Research Peptides In Minnesota: Why Not For Human Consumption Doesn't Protect You Holt Law